Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

058820.KQ

STRONG SELL

CMG Pharmaceutical Co., Ltd. · Healthcare · South Korea · $107M · Avg Vol: $625K/d

14
StockRank
Q
31
V
53
M
17
P/E (TTM)
—
ROE
-4.3%
D/E
0.4x
Dividend %
—
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →

COMPANY DESCRIPTION

CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue54M62M65M69M8.6%
EPS-0.000.030.01-0.05-58.7%
Shares139M139M139M148M+6.4%
Debt4M17M53M47M120.5%
Equity122M125M125M133M2.9%
Op CF3M3M190,954-7M-75.8%
Inv CF-7M-19M-37M9M—
Fin CF4M14M37M622,575—
Loading...
PRICE (1M)-35.9%
0.690.790.901.001.10May 6May 28Jun 18
SMA 50SMA 200
Close
$0.71
RSI (14)
27.4
52W High
$1.53
From 52W High
0.5%

SCORE BREAKDOWN

Quality
31
ROIC
-4.3%39.7
ROE
-4.3%39.9
GP/Assets
20.5%47.7
Op. Margin
-11.5%28.9
FCF/Assets
-17.1%19.6
Piotroski
—7.2
Int. Cover
-2.7x33.4
D/E Ratio
0.44x34.7
Current Ratio
1.25x17.0
Value
53
P/E (TTM)
—N/A
EV/EBITDA
-75.5x95.4
P/FCF
—N/A
P/B
0.8x84.1
P/S
1.5x75.8
Div Yield
—N/A
Momentum
17
52W High %
46%19.6
RS 6M
-165%1.4
SMA 50/200
0.84x20.4
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$107M
P/E (Forward)
—
Gross Margin
56.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 058820.KQ are excluded.

TickerCompanyMkt CapStockRankSignal
058820.KQCMG Pharmaceutical Co., Ltd.(you)$107M14STRONG SELL
000520.KSSamil Pharmaceutical Co.,Ltd$105M14STRONG SELL
256840.KQBNC KOREA, Inc.$131M19STRONG SELL
002390.KSHANDOK Inc.$73M17STRONG SELL
067080.KQDAE HWA Pharmaceutical Co., Ltd.$127M7STRONG SELL
004310.KSHyundai Pharmaceutical Co., Ltd.$117M23SELL
063160.KSCKD Bio Corp.$62M15STRONG SELL
003520.KSYungjin Pharm. Co., Ltd.$158M10STRONG SELL
032300.KQKOREA PHARMA Co., Ltd.$63M12STRONG SELL
293780.KQAptaBio Therapeutics Inc.$91M3STRONG SELL

Peer medians: ROE -1.1% · P/E 17.7x · Gross margin 43.4%

CMG Pharmaceutical Co., Ltd. (058820.KQ) — Stock Score Summary

CMG Pharmaceutical Co., Ltd. (058820.KQ) has a MoatMap StockRank of 14/100 based on Quality (31/100), Value (53/100), and Momentum (17/100) factor scores. The current signal is STRONG SELL.

CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea.

Key Financial Metrics

Price$0.71
Market Cap$107M
Price/Book0.80
Return on Equity-4.3%
Return on Invested Capital-4.3%
Debt/Equity43.77
Gross Margin56.8%
Operating Margin-11.5%
Revenue Growth23.7%
Free Cash Flow$-23K

CMG Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is CMG Pharmaceutical Co., Ltd.’s (058820.KQ) StockRank?
MoatMap’s StockRank for CMG Pharmaceutical Co., Ltd. (058820.KQ) is 14/100, with a Strong Sell signal. It is a composite of Quality (31), Value (53), and Momentum (17) factor ranks across MoatMap’s 20,000+ stock universe.
Does CMG Pharmaceutical Co., Ltd. have an economic moat?
CMG Pharmaceutical Co., Ltd. (058820.KQ) has a Quality factor score of 31/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is CMG Pharmaceutical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for CMG Pharmaceutical Co., Ltd. (058820.KQ) is Strong Sell, based on a StockRank of 14/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is CMG Pharmaceutical Co., Ltd. in?
CMG Pharmaceutical Co., Ltd. (058820.KQ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).
Browse all ranked stocks058820.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock